Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2022-08-01 00:00:00 ET · period of report 2022-08-01 · accession 0001127602-22-020005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-08-01 | 2022-08-01 | LXRX | DEBBANE RAYMOND | Dir | P - Purchase | $2.50 | +982.6K | 5.30M | +23% | +$2.46M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-01 | P | A | 982,600 | $2.50 | 5,303,814 | I By Invus US Partners LLC | — | — |